Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Gilead Sciences
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
This study will test an experimental drug named GS-9883/Emtricitabine/Tenofovir Alafenamide (GS-9883/F/TAF) for the possible treatment of human immunodeficiency virus (HIV) infection in children and adolescents. The purpose of this study is to determine the concentration of GS-9883 in your child’s body, and confirm the safety, tolerability and dose of GS-9883/F/TAF in HIV-1 infected, virologically suppressed adolescents (12 to < 18 years of age) and children (6 to < 12 years of age)
The primary objectives of this study are: - To evaluate the steady state pharmacokinetics (PK) for GS-9883 and confirm the dose of the GS-9883/emtricitabine/tenofovir alafenamide (GS-9883/F/TAF) fixed...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
A study evaluating the Safety and Efficacy of Entospletinib (GS-9973) in combination with standard of care in adult subjects with Relapsed or Refractory Acute Lymphoid Leukemia (ALL)
To evaluate safety of entospletinib (GS-9973) in combination with vincristine (VCR) and dexamethasone in adult subjects with previously treated relapsed or refractory B-cell lineage ALL
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
A study of GS-7977 and Ribavirin in patients with HCV waiting for a liver transplant Ensayo de GS-7977 y Ribavirina en pacientes con VHC que esperan un transplante de hígado
The primary objective of this study is to determine if the administration of a combination of GS-7977 and ribavirin to HCV-infected subjects with hepatocellular carcinoma (HCC) meeting the MILAN crite...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
A study to compare a pediatric tablet or suspension of elvitegravir verses the adult 150 mg tablet in healthy adult volunteers
The primary objective of this study is to evaluate the relative bioavailability of two age-appropriate pediatric formulations (tablet and suspension formulation) of EVG co-administered with ritonavir ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
A study to assess the safety and efficacy of ledipasvir/sofosbuvir in adults with chronic HCV infection
- To determine the antiviral efficacy of ledipasvir/sofosbuvir (LDV/SOF) +/- ribavirin (RBV) in subjects with chronic HCV infection as measured by the proportion of subjects in each treatment group wi...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
A study with sofosbuvir and ribavirin for adolecents and children with chronic Hepatitis C infection
The primary objective of the PK Lead-in Phase of this study is: *To evaluate the steady state pharmacokinetics (PK) and confirm the dose of sofosbuvir (SOF) in HCV-infected pediatric subjects The prim...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
An international study to assess the safety and efficacy of a combination of an approved drug combination in different type of patient, namely patients acutely infected with Hepatitis C virus who are also chronically infected with Human Immunodeficiency Virus (HIV)-1
The primary objective of this study is as follows: • To determine the antiviral efficacy of LDV/SOF FDC Tablet as measured by the proportion of subjects who attain SVR at 12 weeks after discontinua...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
An international study to assess the safety and efficacy of a combination of new investigational drugs in patients with chronic hepatitis C virus infection who have previously failed treatment in a clinical study run by Gilead. Estudio internacional para evaluar la seguridad y eficacia de una combinación de nuevos medicamentos en investigación en pacientes con infección crónica por virus de la hepatitis C cuyo tratamiento previo en un estudio patrocinado por Gilead haya fracasado
The primary objectives of this study are: - To determine the efficacy of sofosbuvir/ledipasvir fixed-dose combination (SOF/LDV FDC) ± ribavirin (RBV) as measured by the proportion of subjects with sus...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences Incorporated
MAJ Il y a 4 ans
A Phase IIa, Double-blind, Randomised, Placebo-Controlled Dose Escalation Study to Evalulate the Safety, Tolerability, Pharmacokinetics and Activity of GS-9450, a Caspase Inhibitor, in Subjects with Chronic Hepatitis C
• To investigate the safety and tolerability of multiple oral doses of GS-9450 in subjects with chronic hepatitis C (HCV).
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
A Phase 2 clinical trial investigating the anti-virus effects, kinetics and safety of GS-5806 in adults with RSV (Respiratory Syncytial Virus) infection
To evaluate the effect of presatovir on RSV viral load in autologous or allogeneic HCT recipients with an acute RSV LRTI
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
5
6
7
8
9
10
Suivant